Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Results Briefing Investor Relations Activity Record Form
An indicative announcement by Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. on granting a third exercise period for the first time in the 2021 stock options incentive plan and reserving the granting of the second exercise period to commence the exercise of rights
Announcement of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. on holding a 2024 semi-annual results briefing
Announcement of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. on the election of members, chairman of the board of directors, chairman of the board of supervisors, appointment of senior management, board secretary and securities affairs representative
Announcement of Resolutions of the First Meeting of the 9th Board of Supervisors of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Legal Opinion of Xinjiang Xinghe Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the First Meeting of the 9th Board of Directors of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Announcement of Progress on Pledged Shares of Controlling Shareholder by Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Announcement on the release and re-pledging of shares by the controlling shareholder of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd.
Xinjiang Baihua Village Pharmaceutical Group Co., Ltd.'s semi-annual report for 2024.
Summary of the 2024 semi-annual report of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd.
Materials for the second interim shareholder meeting of Baihua Village Medicine Group Co., Ltd. in Xinjiang in 2024.
Announcement of Xinjiang Baihua Village Pharmaceutical Group Co., Ltd. on the completion of the cancellation of the stock options in the 2021 stock option incentive plan.
Announcement from Xinjiang Baihua Village Pharmaceutical Group Co., Ltd. regarding the resignation of the securities affairs representative.
Reply from the controlling shareholder regarding the inquiry letter on abnormal fluctuations in the trading of stocks of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Reply regarding the abnormal stock trading of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd. from the actual controller.
Announcement of abnormal fluctuations in the trading of stocks of Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
Notice of Employee Supervisor Election for Xinjiang Baihua Village Pharmaceutical Group Co., Ltd.
Announcement on the First Grant of Stock Options for the Third Exercise Period and Reserved Grant for the Second Exercise Period of the 2021 Stock Option Incentive Plan for Xinjiang Baihua Village Pharmaceutical Group Co., Ltd with the adoption of autonomous exercise model.
No Data